Articles | EuroIntervention

Flashlight

10.4244/EIJ-D-24-00299 • Jul 15, 2024

Splitter – a novel device for leaflet modification in transcatheter aortic valve-in-valve implantation procedures

Feld Y, Lewkowicz S, Fogel T, Kerner A

free

EAPCI Column

Jul 15, 2024

EAPCI Focus on the EAPCI Scientific Programme and Congress Committee

free

Snapshot

Jul 15, 2024

State-of-the-Art on the durability of TAVI; immediate vs staged revascularisation in STEMI patients; the ULTRACOLOR Trial; expanded study results for transapical TMVR; and more

free

Editorial

10.4244/EIJ-E-24-00030 • Jul 15, 2024

Ultrasound is not the panacea for transfemoral access complications

Jolly S, d'Entremont M

free

Viewpoint

10.4244/EIJ-D-24-00164 • Jul 15, 2024

TAVI in moderate aortic stenosis: the earlier the better?

Schofer N, Ludwig S

free

Viewpoint

10.4244/EIJ-D-24-00205 • Jul 15, 2024

Subclinical leaflet thrombosis: should we be concerned?

Dangas G, Bay B

free

State-of-the-Art

10.4244/EIJ-D-23-01050 • Jul 15, 2024

Durability of transcatheter aortic valve implantation

Ternacle J, Hecht S, Eltchaninoff H, Salaun E, Clavel M-A, Côté N, Pibarot P

free

Original Research

10.4244/EIJ-D-23-00882 • Jul 15, 2024

Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease

Scarparo P, Elscot JJ, Kakar H, den Dekker WK, Bennett J, Sabaté M, Esposito G, Ranieri De Caterina A, Vandeloo B, Cummins P, Lenzen M, Daemen J, Brugaletta S, Boersma E, Van Mieghem NM, Diletti R, investigators ftB

free

Snapshot

Jul 1, 2024

Stroke in TAVI; biolimus- vs paclitaxel-coated balloons; target lesion failure after drug-coated balloon PCI; paclitaxel-coated balloons for vulnerable lipid-rich plaques; sirolimus-coated balloon angioplasty for coronary artery disease; and more

free

Editorial

10.4244/EIJ-E-24-00035 • Jul 1, 2024

Angioplasty with drug-coated balloon catheters: the coming tide?

Byrne R, Durand R

free

Editorial

10.4244/EIJ-E-24-00036 • Jul 1, 2024

Aggressive predilatation seeking medial dissection: a prerequisite for a drug-coated balloon-only strategy in de novo coronary lesions?

Adriaenssens T, Bennett J

free

Viewpoint

10.4244/EIJ-E-24-00019 • Jul 1, 2024

Drug-coated balloons for acute coronary syndromes

Scheller B, Eccleshall S

free

Expert Review

10.4244/EIJ-D-23-01087 • Jul 1, 2024

Cerebrovascular events after transcatheter aortic valve implantation

Reddy P, Merdler I, Ben-Dor I, Satler LF, Rogers T, Waksman R

free

Original Research

10.4244/EIJ-D-24-00295 • Jul 1, 2024

Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial

Chen Y, Gao L, Qin Q, Zhang J, Jia S, Wu M, He Y, Fu G, Liu J, Chen H, Tong Q, Yu Z, An J, Qiu C, Xu B, Cao Y, Wang C, Ma G

free

Original Research

10.4244/EIJ-D-23-01006 • Jul 1, 2024

Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions

Lee T, Ashikaga T, Nozato T, Nagata Y, Kaneko M, Miyazaki R, Misawa T, Taomoto Y, Okata S, Nagase M, Horie T, Terui M, Kachi D, Odanaka Y, Matsuda K, Naito M, Koido A, Yonetsu T, Sasano T

free